var data={"title":"Disorders of the hexose monophosphate shunt and glutathione metabolism other than glucose-6-phosphate dehydrogenase deficiency","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Disorders of the hexose monophosphate shunt and glutathione metabolism other than glucose-6-phosphate dehydrogenase deficiency</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/contributors\" class=\"contributor contributor_credentials\">Bertil Glader, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/contributors\" class=\"contributor contributor_credentials\">Stanley L Schrier, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/contributors\" class=\"contributor contributor_credentials\">Jennifer S Tirnauer, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 31, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The red blood cell is protected from oxidant injury via enzymes of the hexose monophosphate (HMP) shunt pathway and those of the glutathione synthetic and metabolic pathways (<a href=\"image.htm?imageKey=HEME%2F77081\" class=\"graphic graphic_figure graphicRef77081 \">figure 1</a> and <a href=\"image.htm?imageKey=HEME%2F75361\" class=\"graphic graphic_figure graphicRef75361 \">figure 2</a>). The most common abnormality in this system is glucose-6-phosphate dehydrogenase deficiency, which can lead to varying degrees of hemolysis. This disorder is discussed in depth separately. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;</a>.)</p><p>Abnormalities have been reported in several of the other enzymes in these two pathways, some of which are associated with increased red cell destruction (hemolysis). These disorders will be reviewed here.</p><p class=\"headingAnchor\" id=\"H318074\"><span class=\"h1\">RED CELL CHANGES IN OXIDANT STATES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When disorders of the hexose monophosphate shunt and glutathione metabolism result in anemia, this happens because of oxidant damage to circulating red cells with resultant decreased survival (ie, increased hemolysis), with the following changes.<u> </u></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Biochemical</strong> &ndash; Increased hemolysis is associated with increases in indirect bilirubin and lactate dehydrogenase and reductions in haptoglobin, and is usually accompanied by an abrupt fall in hemoglobin if hemolysis is severe. If intravascular hemolysis is present, there will be hemoglobinuria, dark urine, and the presence of hemosiderin-laden cells in the urine sediment. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Red cell changes</strong> &ndash; Red cell changes in oxidant-related hemolysis include the presence of microspherocytes, red cell fragments, and eccentrocytes or &quot;bite cells&quot; (<a href=\"image.htm?imageKey=HEME%2F73790\" class=\"graphic graphic_picture graphicRef73790 \">picture 1</a>). Special stains document the production of Heinz bodies, which are collections of denatured globin chains often attached to the red cell membrane. If and when the bone marrow responds to the acute anemia, there will be an increase in reticulocytes.</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The enzyme 6-phosphogluconate dehydrogenase (6PGD) catalyzes the conversion of 6-phosphogluconate to ribulose-5-phosphate and carbon dioxide; in the process, NADPH is generated from NADP. Initial observations suggested that 6PGD deficiency does not alter red cell survival, presumably because NADPH is also generated by the proximal enzyme, glucose-6-phosphate dehydrogenase (G6PD). (See <a href=\"topic.htm?path=genetics-and-pathophysiology-of-glucose-6-phosphate-dehydrogenase-g6pd-deficiency\" class=\"medical medical_review\">&quot;Genetics and pathophysiology of glucose-6-phosphate dehydrogenase (G6PD) deficiency&quot;</a>.)</p><p>While compensated hemolysis with episodic jaundice and possible oxidant sensitivity has been described in combination with partial 6PGD deficiency in two families [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/1,2\" class=\"abstract_t\">1,2</a>], congenital 6PGD deficiency is generally not associated with any hematologic abnormalities. As an example, a mutant &quot;Whitechapel&quot; 6PGD has been described, transmitted as an autosomal recessive trait. Heterozygotes and homozygotes had 50 and 2 to 5 percent of normal enzyme activity, respectively [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/3\" class=\"abstract_t\">3</a>]. Neither heterozygotes nor homozygotes demonstrated clinical or hematologic abnormalities [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">GLUTATHIONE REDUCTASE DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oxidized glutathione (GSSG) is reduced to glutathione (GSH) in the presence of NADPH by the enzyme glutathione reductase (GSSG-R) (<a href=\"image.htm?imageKey=HEME%2F77081\" class=\"graphic graphic_figure graphicRef77081 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/5\" class=\"abstract_t\">5</a>]. This enzyme requires flavin adenine dinucleotide (FAD) as a cofactor and, as a result, normal enzyme activity is dependent upon the dietary availability of the water soluble vitamin <a href=\"topic.htm?path=vitamin-b2-riboflavin-drug-information\" class=\"drug drug_general\">riboflavin</a> (vitamin B2)&nbsp;[<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=overview-of-water-soluble-vitamins#H14\" class=\"medical medical_review\">&quot;Overview of water-soluble vitamins&quot;, section on 'Vitamin B2 (riboflavin)'</a>.)</p><p class=\"headingAnchor\" id=\"H13084810\"><span class=\"h2\">Acquired deficiency</span></p><p class=\"headingAnchor\" id=\"H4725464\"><span class=\"h3\">Nutritional</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acquired partial deficiency of GSSG-R is a relatively common feature of disorders that are compounded by suboptimal nutrition and <a href=\"topic.htm?path=vitamin-b2-riboflavin-drug-information\" class=\"drug drug_general\">riboflavin</a> deficiency, including hospitalized patients with malnutrition, liver disease, or sepsis [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/6,7\" class=\"abstract_t\">6,7</a>]. In a study of 1691 individuals from Saudi Arabia, the overall frequency of acquired GSSG-R deficiency due to riboflavin deficiency in males and females was 17.8 and 22.4 percent, respectively. This could be easily corrected by dietary supplementation with riboflavin in physiologic quantities [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/8\" class=\"abstract_t\">8</a>].</p><p>However, riboflavin-induced acquired partial GSSG-R deficiency is not associated with any clinical or hematologic abnormalities, presumably because the reserve capacity of this enzyme in red cells is quite high [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/9\" class=\"abstract_t\">9</a>].</p><p>An interesting observation was made in a Czech proband and her sister, both of whom had hemoglobin Han&aacute;, an unstable hemoglobin variant with Heinz body hemolytic anemia accompanied by an acquired partial deficiency of GSSG-R due to dietary <a href=\"topic.htm?path=vitamin-b2-riboflavin-drug-information\" class=\"drug drug_general\">riboflavin</a> deficiency. Their mother had the same hemoglobin mutation but with normal GSSG-R activity and was asymptomatic. This report provides evidence that, while partial GSSG-R deficiency by itself may not confer a hematologic abnormality, its presence may alter the clinical manifestation of an unstable hemoglobinopathy [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=unstable-hemoglobin-variants#H1807536\" class=\"medical medical_review\">&quot;Unstable hemoglobin variants&quot;, section on 'Hemolytic anemia'</a>.)</p><p class=\"headingAnchor\" id=\"H4725470\"><span class=\"h3\">Drug-induced</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A profound and irreversible inhibition of GSSG-R occurs in patients receiving the nitrosourea <a href=\"topic.htm?path=carmustine-drug-information\" class=\"drug drug_general\">carmustine</a> (BCNU) in therapeutic doses, not only in erythrocytes, but also in leukocytes, platelets, and other tissues [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/11\" class=\"abstract_t\">11</a>]. While carmustine promotes enhanced susceptibility of normal red cells to oxidant stress [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/12\" class=\"abstract_t\">12</a>], this effect may also enhance or mediate the antitumor effects of this free radical-generating chemotherapeutic agent.</p><p class=\"headingAnchor\" id=\"H13084816\"><span class=\"h2\">Genetically determined deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Homozygous GSSG-R deficiency has been documented in only one family, involving three siblings with favism and bilateral cataracts, offspring of a consanguineous marriage [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/13,14\" class=\"abstract_t\">13,14</a>]. Enzyme activity was not enhanced by incubation of red cell hemolysates with FAD. Despite near absence of erythrocyte GSSG-R activity, the siblings were hematologically normal, except for episodes of hemolysis after the ingestion of fava beans. Very low activity of GSSG-R was found also in leukocytes, but no increased susceptibility to infection was noted [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/15\" class=\"abstract_t\">15</a>]. Both favism and cataracts in the siblings were attributed to reduced levels of GSH, a major antioxidant for both red blood cells and the lens of the eye [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/16\" class=\"abstract_t\">16</a>].</p><p>Other than the above family, there have been no other reports of hereditary GSSG-R deficiency associated with hemolysis, although one patient with severe neonatal jaundice has been described [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/14\" class=\"abstract_t\">14</a>]. In addition, mice homozygous for glutathione reductase deficiency, with only 2 percent of residual enzyme activity, do not have hemolytic anemia [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/17\" class=\"abstract_t\">17</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">GLUTATHIONE PEROXIDASE DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glutathione peroxidase (GSH-Px), a selenium-containing enzyme, catalyzes the oxidation of reduced glutathione (GSH) by hydrogen peroxide, resulting in the production of oxidized glutathione (GSSG) and water (<a href=\"image.htm?imageKey=HEME%2F77081\" class=\"graphic graphic_figure graphicRef77081 \">figure 1</a>). Rare cases of hemolysis in association with moderate deficiency of erythrocyte GSH-Px activity have been described in adults and children [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/18-20\" class=\"abstract_t\">18-20</a>]. The most persuasive case linking deficiency of GSH-Px to hemolysis was that of a Japanese child with chronic non-spherocytic hemolytic anemia [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/21\" class=\"abstract_t\">21</a>]. Her erythrocyte GSH-Px activity was 17 percent of control activity, contrasting with levels of 51 to 66 percent in her hematologically normal parents.</p><p>Levels of red blood cell (RBC) GSH-Px in healthy newborn infants are approximately one-half those seen in older children and adults, with adult levels achieved by 6 to 10 months of age [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/21,22\" class=\"abstract_t\">21,22</a>]. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although GSH-Px deficiency has been incriminated as a cause of neonatal jaundice [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/23\" class=\"abstract_t\">23</a>], no relationship between GSH-Px levels and magnitude of hyperbilirubinemia has been identified in prospective studies [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/24\" class=\"abstract_t\">24</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When cord blood RBCs are stressed with peroxide under conditions preventing regeneration of GSH, the amount of GSH oxidized is similar for cord and adult erythrocytes [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/25\" class=\"abstract_t\">25</a>]. Low GSH-Px activity in cord RBCs thus appears to be without functional significance.</p><p/><p>Two additional observations cast doubt on a causative relation between GSH-PX deficiency and hemolysis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Many healthy normal individuals, particularly those of Jewish or Mediterranean ancestry, have reduced GSH-Px activity without evidence of hemolysis [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/26\" class=\"abstract_t\">26</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low GSH-Px activity, in the absence of hemolysis, has been observed in normal people from New Zealand with <a href=\"topic.htm?path=selenium-drug-information\" class=\"drug drug_general\">selenium</a> deficiency [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/27,28\" class=\"abstract_t\">27,28</a>].</p><p/><p>Accordingly, any patient with hemolytic anemia and reduced GSH-Px activity should be extensively evaluated for another enzymopathy as the underlying cause.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">DEFECTS IN GLUTATHIONE SYNTHESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The tripeptide glutathione (GSH) is actively synthesized in red cells, with an intracellular half-life of four days due, in part, to cellular efflux of oxidized glutathione (GSSG). Red blood cells (RBCs) are capable of de novo GSH synthesis, accomplished by two critical enzymes (<a href=\"image.htm?imageKey=HEME%2F75361\" class=\"graphic graphic_figure graphicRef75361 \">figure 2</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gamma-glutamyl-cysteine synthetase (gamma GCSynth), which catalyzes formation of gamma-glutamyl-cysteine from glutamic acid and cysteine.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glutathione synthetase (GSHSynth), which catalyzes the formation of GSH from gamma-glutamyl-cysteine and glycine.</p><p/><p>In many tissues, but not RBCs, these two enzymes are part of the gamma glutamyl cycle involved in the synthesis and degradation of GSH and perhaps also in amino acid transport across cell membranes [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/29\" class=\"abstract_t\">29</a>]. Hereditary hemolytic anemia, characterized by reduced GSH content, has been reported in patients with deficiencies of both gamma GCSynth and GSHSynth activity [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/30\" class=\"abstract_t\">30</a>]. The clinical effects of these disorders depend upon the severity of enzyme deficiency and whether this metabolic cycle is affected in non-erythroid tissues, as well.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Gamma-glutamyl-cysteine synthetase deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gamma-glutamyl cysteine synthetase catalyzes the first step in glutathione synthesis. It consists of two subunits, heavy and light, with the heavy subunit containing the catalytic site [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/31\" class=\"abstract_t\">31</a>]. Mutations in the catalytic subunit of this enzyme, leading to deficiency and low levels of red cell glutathione, have been detected in a number of affected subjects [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/32\" class=\"abstract_t\">32</a>].</p><p>Gamma-glutamyl-cysteine synthetase (gammaGCSynth) deficiency is a rare autosomal recessive hemolytic anemia, initially described in two siblings with a life-long history of mild hemolytic anemia, jaundice, gallstones, and splenomegaly. In addition, they manifested severe neurologic dysfunction in the form of spinocerebellar degeneration, along with generalized aminoaciduria [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/33,34\" class=\"abstract_t\">33,34</a>]. Homozygotes had erythrocyte GSH levels approximately 5 percent of normal, markedly reduced gamma GCSynth activity, and hemolytic anemia. Heterozygotes had 50 percent of normal gammaGCSynth activity, normal erythrocyte GSH levels, and no hematologic disease.</p><p>A total of eight unrelated probands with hemolytic anemia had been reported as of 2007; one-half were associated with severe neurologic dysfunction [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/35,36\" class=\"abstract_t\">35,36</a>]. </p><p>There is no specific therapy for GCSynth deficiency, although it would seem prudent to obtain periodic gallbladder ultrasound examinations, since some affected patients have required cholecystectomy for gallstones.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Glutathione synthetase deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glutathione synthetase (GSHSynth) deficiency has been incriminated as the cause of chronic hemolytic anemia and jaundice when the deficiency is isolated to RBCs. When the deficiency is found in many tissues, it is responsible for a more generalized syndrome characterized by hemolysis, metabolic acidosis, and mental deterioration [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/37,38\" class=\"abstract_t\">37,38</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The first syndrome has been described in several families [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/30,39\" class=\"abstract_t\">30,39</a>]. Splenomegaly has been noted in approximately one half of the reported cases. Exposure to oxidant drugs and to fava beans has occasioned temporary acceleration of hemolysis. A concurrent deficiency of glutathione-S-transferase in these patients is thought to be caused by the instability of this enzyme in the absence of adequate intracellular concentrations of reduced glutathione (GSH) [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/40\" class=\"abstract_t\">40</a>]. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency#H7\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;, section on 'Inciting drugs, foods, illnesses'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The more generalized syndrome (5-oxoprolinuria, pyroglutamic aciduria, MIM#266130) is characterized by mild hemolytic anemia, metabolic acidosis presenting in the newborn period, and progressive cerebral and cerebellar degeneration [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/38,41-43\" class=\"abstract_t\">38,41-43</a>]. Acidosis is caused by the accumulation of 5-oxoproline (5-oxyproline, pyroglutamic acid), a metabolic product of gamma-glutamyl-cysteine. The latter dipeptide is produced in large quantities because of the loss of feedback inhibition of gamma-glutamyl-cysteine synthetase by GSH (<a href=\"image.htm?imageKey=HEME%2F75361\" class=\"graphic graphic_figure graphicRef75361 \">figure 2</a>). The disorder may first be detected in newborn metabolic screening programs [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/44\" class=\"abstract_t\">44</a>]. (See <a href=\"topic.htm?path=myeloperoxidase-deficiency-and-other-enzymatic-wbc-defects-causing-immunodeficiency#H14\" class=\"medical medical_review\">&quot;Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency&quot;, section on 'Glutathione pathway alterations'</a>.)</p><p/><p>This disorder is suspected in patients with hemolytic anemia and markedly reduced red blood cell GSH content. Virtually no GSHSynth activity is detected in homozygous-deficient individuals [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/39\" class=\"abstract_t\">39</a>]. </p><p class=\"headingAnchor\" id=\"H13085007\"><span class=\"h3\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rarely, therapy with <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> is effective for the hematologic consequences of GSH deficiency [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/45\" class=\"abstract_t\">45</a>], although its efficacy has been questioned [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/43\" class=\"abstract_t\">43</a>]. As in patients with G6PD deficiency, exposure to drugs and chemicals with oxidant potential should be avoided. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency#H381605357\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;, section on 'Management'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one patient, splenectomy was efficacious in modifying the anemia, although there was a persistent reticulocytosis post-splenectomy. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In individuals with increased production of 5-oxoproline, administration of oral alkalinizing agents (eg, bicarbonate, citrate, or lactate) may be necessary for control of the resulting acidosis [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/41\" class=\"abstract_t\">41</a>]. (See <a href=\"topic.htm?path=approach-to-the-adult-with-metabolic-acidosis#H15\" class=\"medical medical_review\">&quot;Approach to the adult with metabolic acidosis&quot;, section on 'Overview of therapy'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">GLUTATHIONE S-TRANSFERASE DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glutathione S-transferase (GSH-ST) functions to detoxify various xenobiotics by conjugating them with glutathione, and may play a role in detoxifying carcinogens [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/46\" class=\"abstract_t\">46</a>]. It may also play a role in the active transport of such conjugates from the red cell as well as protecting hematopoietic stem cells from oxidative damage. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-of-urothelial-transitional-cell-carcinoma-of-the-bladder#H32\" class=\"medical medical_review\">&quot;Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder&quot;, section on 'Detoxification of carcinogens'</a> and <a href=\"topic.htm?path=aplastic-anemia-pathogenesis-clinical-manifestations-and-diagnosis#H6\" class=\"medical medical_review\">&quot;Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Drugs, radiation, toxins'</a>.)</p><p>Deficiency of GSH-ST has been detected in an adult male with mild hemolytic anemia, splenomegaly, indirect hyperbilirubinemia, and cholelithiasis [<a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/47\" class=\"abstract_t\">47</a>]. Absence of other affected family members has prevented further investigation of the relationship between this enzyme deficiency and hemolysis.</p><p class=\"headingAnchor\" id=\"H6214538\"><span class=\"h1\">AVAILABLE REFERENCE LABORATORIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A small number of reference laboratories are available for special testing for the various disorders discussed in this review:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most glycolytic enzymes, G6PD, and 6PGD can be assayed at the Mayo Medical Laboratories at Mayo Clinic (<a href=\"http://www.mayomedicallaboratories.com/&amp;token=XsuOnnm5zlcDDa3AH9M57v0B+li3irzSGF5xIZzr3Ni18/MbXPqa9+qr24WNQOAi&amp;TOPIC_ID=7128\" target=\"_blank\" class=\"external\">www.mayomedicallaboratories.com</a>; phone contact: 800-533-1710) or the Red Cell Special Studies Laboratory at Stanford University (<a href=\"http://www.stanfordlab.com/&amp;token=h4xV+F8iSECdYZqAWwlsY6al88WC0o3CIUXBGN/XSV7Gu+xh5ayR39ZvMBOjGYTw&amp;TOPIC_ID=7128\" target=\"_blank\" class=\"external\">www.stanfordlab.com</a>; phone contact: 877-717-3733).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glutathione synthetic enzymes are screened for by measuring red cell glutathione, available at both Mayo Clinic and Stanford.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no commercial laboratory available for specific assay of these enzymes. Glutathione reductase and glutathione peroxidase are not considered causes of hemolysis and no commercially available testing for these enzymes is available.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the presence of a hemolytic anemia associated with low glutathione levels, molecular genetics testing should be employed. Molecular tests for these disorders are available at Cincinnati Children's Molecular Genetics Laboratory (<a href=\"http://www.cincinnatichildrens.org/service/d/diagnostic-labs/molecular-genetics/default/&amp;token=n3fx4sTcbs22kLBK2FMjFSNiBXFIAXwOlvFDHxNBoczzz/WKd9OiJe7pPTNo94udzLkJCp+AykenIcjDAMvo3Axzcseglo7UF3yTaLRW5OWvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=7128\" target=\"_blank\" class=\"external\">www.cincinnatichildrens.org/moleculargenetics</a>; phone contact: 513-636-4474) and the Blood Disease Reference Laboratory Program at Yale University (<a href=\"http://www.yaleblooddiseaselab.org/&amp;token=0dX+7CBRLbHVi4yMe2Ez2D3GQ/XAMX15f2bembrgMGZPU7arsSqUCDdYkRDa1E5O&amp;TOPIC_ID=7128\" target=\"_blank\" class=\"external\">www.yaleblooddiseaselab.org</a>; phone contact: 203-737-1349).</p><p/><p class=\"headingAnchor\" id=\"H3427445743\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-anemia-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Anemia in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11580465\"><span class=\"h1\">SUMMARY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The red blood cell (RBC) is protected from oxidant injury via enzymes of the hexose monophosphate (HMP) shunt pathway and those of the glutathione pathway. Inherited deficiencies in some of the enzymes in these two pathways result in either life-long hemolytic anemia or hemolysis on exposure to agents with oxidizing potential. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Defects associated with hemolysis</strong> &ndash; Enzyme defects associated with increased red cell destruction include the following. All are extremely rare with the exception of glucose-6-phosphate dehydrogenase deficiency.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong> &ndash; The most common abnormality in this system is G6PD deficiency, which can lead to varying degrees of hemolysis. This disorder is discussed separately. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>6-phosphogluconate dehydrogenase (6PGD) deficiency</strong> &ndash; Compensated hemolysis with episodic jaundice and possible oxidant sensitivity has been described in combination with partial 6PGD deficiency in two families. (See <a href=\"#H2\" class=\"local\">'6-phosphogluconate dehydrogenase deficiency'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Gamma-glutamyl-cysteine synthetase deficiency</strong> &ndash; This is a rare autosomal recessive hemolytic anemia in association with severe neurologic dysfunction (spinocerebellar degeneration) and generalized aminoaciduria. (See <a href=\"#H6\" class=\"local\">'Gamma-glutamyl-cysteine synthetase deficiency'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Glutathione synthetase deficiency</strong> &ndash; This deficiency has been associated with chronic hemolytic anemia when isolated to RBCs. When the deficiency is found in many tissues, it is associated with hemolysis, metabolic acidosis, and mental deterioration. Administration of oral alkalinizing agents may be necessary for control of the resulting acidosis. (See <a href=\"#H7\" class=\"local\">'Glutathione synthetase deficiency'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Management</strong> &ndash; Management of hemolytic anemia in the above-noted conditions is similar, including avoidance of agents with oxidant potential (<a href=\"image.htm?imageKey=HEME%2F74254\" class=\"graphic graphic_table graphicRef74254 \">table 1</a>), prophylactic <a href=\"topic.htm?path=folic-acid-drug-information\" class=\"drug drug_general\">folic acid</a>, and red cell transfusions for severe hemolysis. This subject is discussed in depth separately. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency#H381605357\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;, section on 'Management'</a>.)</p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/1\" class=\"nounderline abstract_t\">Caprari P, Caforio MP, Cianciulli P, et al. 6-Phosphogluconate dehydrogenase deficiency in an Italian family. Ann Hematol 2001; 80:41.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/2\" class=\"nounderline abstract_t\">Vives Corrons JL, Colomer D, Pujades A, et al. Congenital 6-phosphogluconate dehydrogenase (6PGD) deficiency associated with chronic hemolytic anemia in a Spanish family. Am J Hematol 1996; 53:221.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/3\" class=\"nounderline abstract_t\">Parr CW, Fitch LI. Inherited quantitative variations of human phosphogluconate dehydrogenase. Ann Hum Genet 1967; 30:339.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/4\" class=\"nounderline abstract_t\">Dern RJ, Brewer GJ, Tashian RE, Shows TB. Hereditary variation of erythrocytic 6-phosphogluconate dehydrogenase. J Lab Clin Med 1966; 67:255.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/5\" class=\"nounderline abstract_t\">Krauth-Siegel RL, Blatterspiel R, Saleh M, et al. Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem 1982; 121:259.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/6\" class=\"nounderline abstract_t\">Cole HS, Lopez R, Epel R, et al. Nutritional deficiencies in institutionalized mentally retarded and physically disabled individuals. Am J Ment Defic 1985; 89:552.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/7\" class=\"nounderline abstract_t\">Frischer H. Erythrocytic glutathione reductase deficiency in a hospital population in the United States. Am J Hematol 1977; 2:327.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/8\" class=\"nounderline abstract_t\">Warsy AS, el-Hazmi MA. Glutathione reductase deficiency in Saudi Arabia. East Mediterr Health J 1999; 5:1208.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/9\" class=\"nounderline abstract_t\">Frischer H, Ahmad T. Consequences of erythrocytic glutathione reductase deficiency. J Lab Clin Med 1987; 109:583.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/10\" class=\"nounderline abstract_t\">Mojzikova R, Dolezel P, Pavlicek J, et al. Partial glutathione reductase deficiency as a cause of diverse clinical manifestations in a family with unstable hemoglobin (Hemoglobin Han&aacute;, &beta;63(E7) His-Asn). Blood Cells Mol Dis 2010; 45:219.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/11\" class=\"nounderline abstract_t\">Frischer H, Ahmad T. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU&quot; [1,3-bis(chloroethyl)-1-nitrosourea]. J Lab Clin Med 1977; 89:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/12\" class=\"nounderline abstract_t\">Sagone AL Jr, Burton GM. The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes. Am J Hematol 1979; 7:97.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/13\" class=\"nounderline abstract_t\">Loos H, Roos D, Weening R, Houwerzijl J. Familial deficiency of glutathione reductase in human blood cells. Blood 1976; 48:53.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/14\" class=\"nounderline abstract_t\">Kamerbeek NM, van Zwieten R, de Boer M, et al. Molecular basis of glutathione reductase deficiency in human blood cells. Blood 2007; 109:3560.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/15\" class=\"nounderline abstract_t\">Roos D, Weening RS, Voetman AA, et al. Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood 1979; 53:851.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/16\" class=\"nounderline abstract_t\">Kumar D, Lim JC, Donaldson PJ. A link between maternal malnutrition and depletion of glutathione in the developing lens: a possible explanation for idiopathic childhood cataract? Clin Exp Optom 2013; 96:523.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/17\" class=\"nounderline abstract_t\">Pretsch W. Glutathione reductase activity deficiency in homozygous Gr1a1Neu mice does not cause haemolytic anaemia. Genet Res 1999; 73:1.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/18\" class=\"nounderline abstract_t\">Steinberg M, Brauer MJ, Necheles TF. Acute hemolytic anemia associated with erythrocyte glutathione-peroxidase deficiency. Arch Intern Med 1970; 125:302.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/19\" class=\"nounderline abstract_t\">Boivin P, et al. Anemie hemolytique avec deficit en glutathion-peroxidase chez un adulte. Enzyme 1969; 10:68.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/20\" class=\"nounderline abstract_t\">Gondo H, Ideguchi H, Hayashi S, Shibuya T. Acute hemolysis in glutathione peroxidase deficiency. Int J Hematol 1992; 55:215.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/21\" class=\"nounderline abstract_t\">Nishimura Y, Chida N, Hayashi T, Arakawa T. Homozygous glutathione-peroxidase deficiency of erythrocytes and leukocytes. Tohoku J Exp Med 1972; 108:207.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/22\" class=\"nounderline abstract_t\">Glader BE, Conrad ME. Decreased glutathione peroxidase in neonatal erythrocytes: lack of relation to hydrogen peroxide metabolism. Pediatr Res 1972; 6:900.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/23\" class=\"nounderline abstract_t\">Miwa S, Nakashima K, Ariyoshi K, et al. Heterozygous erythrocyte glutathione peroxidase deficiency associated with neonatal hyperbilirubinemia found in a Japanese family. Nihon Ketsueki Gakkai Zasshi 1974; 37:266.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/24\" class=\"nounderline abstract_t\">Whaun JM, Oski FA. Relation of red blood cell glutathione peroxidase to neonatal jaundice. J Pediatr 1970; 76:555.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/25\" class=\"nounderline abstract_t\">Gross RT, Bracci R, Rudolph N, et al. Hydrogen peroxide toxicity and detoxification in the erythrocytes of newborn infants. Blood 1967; 29:481.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/26\" class=\"nounderline abstract_t\">Beutler E, Matsumoto F. Ethnic variation in red cell glutathione peroxidase activity. Blood 1975; 46:103.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/27\" class=\"nounderline abstract_t\">Thomson CD, Robinson MF, Campbell DR, Rea HM. Effect of prolonged supplementation with daily supplements of selenomethionine and sodium selenite on glutathione peroxidase activity in blood of New Zealand residents. Am J Clin Nutr 1982; 36:24.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/28\" class=\"nounderline abstract_t\">Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and glutathione peroxidase activities in whole blood of New Zealand residents. Br J Nutr 1977; 37:457.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/29\" class=\"nounderline abstract_t\">Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2007; 2:16.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/30\" class=\"nounderline abstract_t\">Hirono A, Iyori H, Sekine I, et al. Three cases of hereditary nonspherocytic hemolytic anemia associated with red blood cell glutathione deficiency. Blood 1996; 87:2071.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/31\" class=\"nounderline abstract_t\">Beutler E, Gelbart T, Kondo T, Matsunaga AT. The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency. Blood 1999; 94:2890.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/32\" class=\"nounderline abstract_t\">Hamilton D, Wu JH, Alaoui-Jamali M, Batist G. A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood 2003; 102:725.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/33\" class=\"nounderline abstract_t\">Richards F 2nd, Cooper MR, Pearce LA, et al. Familial spinocerebellar degeneration, hemolytic anemia, and glutathione deficiency. Arch Intern Med 1974; 134:534.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/34\" class=\"nounderline abstract_t\">Konrad PN, Richards F 2nd, Valentine WN, Paglia DE. -Glutamyl-cysteine synthetase deficiency. A cause of hereditary hemolytic anemia. N Engl J Med 1972; 286:557.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/35\" class=\"nounderline abstract_t\">Beutler E, Moroose R, Kramer L, et al. Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood 1990; 75:271.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/36\" class=\"nounderline abstract_t\">Ma&ntilde;&uacute; Pereira M, Gelbart T, Ristoff E, et al. Chronic non-spherocytic hemolytic anemia associated with severe neurological disease due to gamma-glutamylcysteine synthetase deficiency in a patient of Moroccan origin. Haematologica 2007; 92:e102.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/37\" class=\"nounderline abstract_t\">Nj&aring;lsson R. Glutathione synthetase deficiency. Cell Mol Life Sci 2005; 62:1938.</a></li><li class=\"breakAll\">Larsson A, Anderson ME. Glutathione synthetase deficiency and other disorders of the gamma-glutamyl cycle. In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, et al. (Eds), McGraw-Hill, New York 2001. p.2205.</li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/39\" class=\"nounderline abstract_t\">Mohler DN, Majerus PW, Minnich V, et al. Glutathione synthetase deficiency as a cause of hereditary hemolytic disease. N Engl J Med 1970; 283:1253.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/40\" class=\"nounderline abstract_t\">Beutler E, Gelbart T, Pegelow C. Erythrocyte glutathione synthetase deficiency leads not only to glutathione but also to glutathione-S-transferase deficiency. J Clin Invest 1986; 77:38.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/41\" class=\"nounderline abstract_t\">Spielberg SP, Kramer LI, Goodman SI, et al. 5-oxoprolinuria: biochemical observations and case report. J Pediatr 1977; 91:237.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/42\" class=\"nounderline abstract_t\">Skullerud K, Marstein S, Schrader H, et al. The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria). Acta Neuropathol 1980; 52:235.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/43\" class=\"nounderline abstract_t\">Prchal JT, Crist WM, Roper M, Wellner VP. Hemolytic anemia, recurrent metabolic acidosis, and incomplete albinism associated with glutathione synthetase deficiency. Blood 1983; 62:754.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/44\" class=\"nounderline abstract_t\">Simon E, Vogel M, Fingerhut R, et al. Diagnosis of glutathione synthetase deficiency in newborn screening. J Inherit Metab Dis 2009; 32 Suppl 1:S269.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/45\" class=\"nounderline abstract_t\">Boxer LA, Oliver JM, Spielberg SP, et al. Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med 1979; 301:901.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/46\" class=\"nounderline abstract_t\">Wiencke JK, Kelsey KT, Lamela RA, Toscano WA Jr. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 1990; 50:1585.</a></li><li><a href=\"https://www.uptodate.com/contents/disorders-of-the-hexose-monophosphate-shunt-and-glutathione-metabolism-other-than-glucose-6-phosphate-dehydrogenase-deficiency/abstract/47\" class=\"nounderline abstract_t\">Beutler E, Dunning D, Dabe IB, Forman L. Erythrocyte glutathione S-transferase deficiency and hemolytic anemia. Blood 1988; 72:73.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 7128 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11580465\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H318074\" id=\"outline-link-H318074\">RED CELL CHANGES IN OXIDANT STATES</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">GLUTATHIONE REDUCTASE DEFICIENCY</a><ul><li><a href=\"#H13084810\" id=\"outline-link-H13084810\">Acquired deficiency</a><ul><li><a href=\"#H4725464\" id=\"outline-link-H4725464\">- Nutritional</a></li><li><a href=\"#H4725470\" id=\"outline-link-H4725470\">- Drug-induced</a></li></ul></li><li><a href=\"#H13084816\" id=\"outline-link-H13084816\">Genetically determined deficiency</a></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">GLUTATHIONE PEROXIDASE DEFICIENCY</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">DEFECTS IN GLUTATHIONE SYNTHESIS</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Gamma-glutamyl-cysteine synthetase deficiency</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Glutathione synthetase deficiency</a><ul><li><a href=\"#H13085007\" id=\"outline-link-H13085007\">- Management</a></li></ul></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">GLUTATHIONE S-TRANSFERASE DEFICIENCY</a></li><li><a href=\"#H6214538\" id=\"outline-link-H6214538\">AVAILABLE REFERENCE LABORATORIES</a></li><li><a href=\"#H3427445743\" id=\"outline-link-H3427445743\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H11580465\" id=\"outline-link-H11580465\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"HEME/7128|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/77081\" class=\"graphic graphic_figure\">- G6PD function</a></li><li><a href=\"image.htm?imageKey=HEME/75361\" class=\"graphic graphic_figure\">- Glutathione synthesis pathway</a></li></ul></li><li><div id=\"HEME/7128|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/73790\" class=\"graphic graphic_picture\">- Heinz body hemolytic anemia</a></li></ul></li><li><div id=\"HEME/7128|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/74254\" class=\"graphic graphic_table\">- G6PD deficiency medicines safety</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aplastic-anemia-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-metabolic-acidosis\" class=\"medical medical_review\">Approach to the adult with metabolic acidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-risk-factors-of-urothelial-transitional-cell-carcinoma-of-the-bladder\" class=\"medical medical_review\">Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-and-pathophysiology-of-glucose-6-phosphate-dehydrogenase-g6pd-deficiency\" class=\"medical medical_review\">Genetics and pathophysiology of glucose-6-phosphate dehydrogenase (G6PD) deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=myeloperoxidase-deficiency-and-other-enzymatic-wbc-defects-causing-immunodeficiency\" class=\"medical medical_review\">Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">Overview of water-soluble vitamins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-anemia-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Anemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=unstable-hemoglobin-variants\" class=\"medical medical_review\">Unstable hemoglobin variants</a></li></ul></div></div>","javascript":null}